AMRX
AMRX's valuation is historically cheap while fundamentals are somewhat mixed and the outlook is broadly stable, though analyst coverage is limited.
AMRX vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 35x | 218x | 84% lower-84% |
| PE percentile | 24 | 50 | 53% lower-53% |
| EPS | $0.49 | -$0.25 | $0.74 higher+$0.74 |
| FCF | $83.1M | $182.7M | 55% lower-55% |
| Loading historical comparisons… | |||
AMRX’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.
AMRX Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Stable |
| Forward earnings | Stable |
| Forward revenue | Stable |
| Forward profitability | Strongly expanding |
| Analyst coverage | Limited |
| Estimate dispersion | Tight |
AMRX’s outlook is generally stable, though analyst coverage is limited.
AMRX PE Valuation
This table applies AMRX's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
AMRX Earnings Per Share
This chart tracks AMRX's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
AMRX Quarterly Revenue
This chart tracks AMRX's quarterly revenue over time and shows how sales are changing from year to year.
AMRX Free Cash Flow
This chart tracks AMRX's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
AMRX Total Shares
This chart tracks changes in AMRX's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
AMRX Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
AMRX PE vs Healthcare Sector
This chart compares AMRX's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
AMRX Weekly Price
This chart uses AMRX's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
AMRX Weekly Moving Averages
This chart compares AMRX's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
AMRX Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
NVO
NVO's valuation appears fair, fundamentals are somewhat mixed and expected margin pressure limits the outlook, though analyst coverage is limited.
NVO vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 11x | 28x | 62% lower-62% |
| PE percentile | 5.4 | 50 | 89% lower-89% |
| EPS | $4.09 | $2.36 | 74% higher+74% |
| FCF | $7.6B | $8.5B | 10% lower-10% |
| Loading historical comparisons… | |||
NVO’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Strongly improving |
| Forward earnings | Strong growth |
| Forward revenue | Decline |
| Forward profitability | Strongly contracting |
| Analyst coverage | Limited |
| Estimate dispersion | Moderate |
NVO’s outlook is mixed, with declining sales expectations a concern.
NVO PE Valuation
This table applies NVO's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
NVO Earnings Per Share
This chart tracks NVO's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
NVO Quarterly Revenue
This chart tracks NVO's quarterly revenue over time and shows how sales are changing from year to year.
NVO Free Cash Flow
This chart tracks NVO's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
NVO Total Shares
This chart tracks changes in NVO's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
NVO Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
NVO PE vs Healthcare Sector
This chart compares NVO's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
NVO Weekly Price
This chart uses NVO's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
NVO Weekly Moving Averages
This chart compares NVO's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
NVO Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.